C07D 209/02
Condensed with one carbocyclic ring
Official title: condensed with one carbocyclic ring
C07D209/02 (Condensed with one carbocyclic ring) appears on 10,602 US grants and 9,131 published applications in this corpus.
Search patents in C07D- Granted patents
- 10,602
- Published applications
- 9,131
- Assignees
- 3,337
- Inventors
- 25,892
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 162 | 0 |
| 1977 | 147 | 0 |
| 1978 | 182 | 0 |
| 1979 | 106 | 0 |
| 1980 | 139 | 0 |
| 1981 | 132 | 0 |
| 1982 | 123 | 0 |
| 1983 | 137 | 0 |
| 1984 | 165 | 0 |
| 1985 | 156 | 0 |
| 1986 | 148 | 0 |
| 1987 | 140 | 0 |
| 1988 | 115 | 0 |
| 1989 | 172 | 0 |
| 1990 | 154 | 0 |
| 1991 | 163 | 0 |
| 1992 | 150 | 0 |
| 1993 | 188 | 0 |
| 1994 | 152 | 0 |
| 1995 | 155 | 0 |
| 1996 | 203 | 0 |
| 1997 | 234 | 0 |
| 1998 | 230 | 0 |
| 1999 | 221 | 0 |
| 2000 | 219 | 0 |
| 2001 | 266 | 50 |
| 2002 | 240 | 253 |
| 2003 | 230 | 409 |
| 2004 | 214 | 478 |
| 2005 | 206 | 481 |
| 2006 | 266 | 416 |
| 2007 | 263 | 433 |
| 2008 | 260 | 421 |
| 2009 | 280 | 447 |
| 2010 | 316 | 476 |
| 2011 | 260 | 378 |
| 2012 | 285 | 306 |
| 2013 | 271 | 334 |
| 2014 | 309 | 345 |
| 2015 | 271 | 346 |
| 2016 | 283 | 378 |
| 2017 | 313 | 357 |
| 2018 | 258 | 321 |
| 2019 | 283 | 325 |
| 2020 | 256 | 321 |
| 2021 | 221 | 283 |
| 2022 | 195 | 310 |
| 2023 | 202 | 381 |
| 2024 | 218 | 369 |
| 2025 | 192 | 277 |
| 2026 | 151 | 236 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted indole compounds and the use thereof6 Oct 2026US 12,753,154 B2Trobio Therapeutics Pty Ltd
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Inhibitors of tyrosine kinase22 Sep 2026US 12,740,982 B2BridGene Biosciences, Inc.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt)8 Oct 2026US 2026/0308121 A1Gh Research Ireland Limited
- 1-oxoisoindolin-2-yl amide activators of vcp and derivatives thereof8 Oct 2026US 2026/0308122 A1
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Fused pyrrolidine-2-one herbicidal compounds1 Oct 2026US 2026/0293894 A1Syngenta Crop Protection AG
Most cited
By later US patents
- Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them565US 5,514,718 AMerck Sharp & Dohme Corp. · 1996
- System and methods for nucleic acid sequencing of single molecules by polymerase synthesis410US 6,255,083 B12001
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- Fluorescent indicator dyes for calcium ions238US 4,603,209 AThe Regents of the University of California · 1986